Charles River Laboratories | CRL - Current Assets

Stock Price
169.80
Daily Change
2.06 1.23%
Monthly
2.36%
Yearly
48.09%
Q2 Forecast
179.83

Charles River Laboratories reported $1.45B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agilent USD 4.62B 21M Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Cardinal Health USD 39.23B 693M Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Cigna USD 47.81B 1.08B Dec/2025
Concord Medical Services Hldg CNY 1.03B 174.49M Jun/2025
CVS Health USD 74.71B 2.4B Dec/2025
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 2.02B 49M Dec/2025
Elevance Health USD 67.03B 4.03B Mar/2026
Galapagos EUR 3.08B 82.56M Dec/2025
Humana USD 32.73B 19M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Intrexon USD 23.72M 45.04M Jun/2024
IQVIA Holdings USD 6.25B 270M Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
McKesson USD 59.7B 190M Dec/2025
Merck EUR 13.23B 354M Dec/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Quest Diagnostics USD 2.57B 188M Mar/2026
Revvity USD 2.24B 95.96M Dec/2025
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
United Therapeutics USD 3.7B 208.5M Dec/2025
UnitedHealth USD 90.58B 4.49B Dec/2025
Veradigm USD 679.65M 131.12M Dec/2022
Waters USD 1.99B 69.86M Dec/2025
West Pharmaceutical Services USD 1.83B 151.4M Mar/2026